» Articles » PMID: 39027239

The Clinical Antiprotozoal Drug Nitazoxanide and Its Metabolite Tizoxanide Extend Lifespan and Healthspan

Overview
Publisher Elsevier
Specialty Pharmacology
Date 2024 Jul 19
PMID 39027239
Authors
Affiliations
Soon will be listed here.
Abstract

The drugs extending healthspan in clinic have always been searched. Nitazoxanide is an FDA-approved clinical antiprotozoal drug. Nitazoxanide is rapidly metabolized to tizoxanide after absorption . Our previous studies find that nitazoxanide and its metabolite tizoxanide induce mild mitochondrial uncoupling and activate cellular AMPK, oral nitazoxanide protects against experimental hyperlipidemia, hepatic steatosis, and atherosclerosis. Here, we demonstrate that both nitazoxanide and tizoxanide extend the lifespan and healthspan of through Akt/AMPK/sir 2.1/daf16 pathway. Additionally, both nitazoxanide and tizoxanide improve high glucose-induced shortening of lifespan. Nitazoxanide has been a clinical drug with a good safety profile, we suggest that it is a novel anti-aging drug.

References
1.
Green C, Lamming D, Fontana L . Molecular mechanisms of dietary restriction promoting health and longevity. Nat Rev Mol Cell Biol. 2021; 23(1):56-73. PMC: 8692439. DOI: 10.1038/s41580-021-00411-4. View

2.
Walsh K, McAulay K, Lee M, Vilbrun S, Mathurin L, Jean Francois D . Early Bactericidal Activity Trial of Nitazoxanide for Pulmonary Tuberculosis. Antimicrob Agents Chemother. 2020; 64(5). PMC: 7179618. DOI: 10.1128/AAC.01956-19. View

3.
Chen X, Dong Y, Yu Y, Jiang M, Bu W, Li P . Anthelmintic nitazoxanide protects against experimental pulmonary fibrosis. Br J Pharmacol. 2023; 180(23):3008-3023. DOI: 10.1111/bph.16190. View

4.
Tulipano G . Integrated or Independent Actions of Metformin in Target Tissues Underlying Its Current Use and New Possible Applications in the Endocrine and Metabolic Disorder Area. Int J Mol Sci. 2021; 22(23). PMC: 8658259. DOI: 10.3390/ijms222313068. View

5.
Dubreuil L, Houcke I, Mouton Y, Rossignol J . In vitro evaluation of activities of nitazoxanide and tizoxanide against anaerobes and aerobic organisms. Antimicrob Agents Chemother. 1996; 40(10):2266-70. PMC: 163516. DOI: 10.1128/AAC.40.10.2266. View